Presentations Cortexyme Corporate Overview March 2021 SITC 2020 Poster Presentation #676: "PD-L1 is induced by the periodontal pathogen Porphyromonas gingivalis and can be blocked by small molecule gingipain inhibitors, including atuzaginstat" (November 9-14, 2020) CTAD 2020 Oral Presentation #OC19: "Phase 2/3 GAIN trial of COR388 (atuzaginstat), a novel bacterial virulence factor inhibitor for the treatment of Alzheimer’s disease: Update and baseline Data" (November 5, 2020) AAIC 2020 Poster #47058: “Targeting Porphyromonas gingivalis to treat Alzheimer’s disease and comorbid cardiovascular disease” (July 2020) AAIC 2020 Poster #40578: “COR388 (atuzaginstat), a novel gingipain inhibitor, decreases fragmentation of ApoE in the central nervous system of Alzheimer's disease patients” (July 2020) AAIC 2020 Poster #44023: “Comprehensive Alzheimer’s pathology is induced by Porphyromonas gingivalis infection: COR388 (atuzaginstat) and other gingipain inhibitors protect against synaptic loss” (July 2020) Poster for AAT-AD/PD 2020 Focus Meeting, April 2-5, 2020
SITC 2020 Poster Presentation #676: "PD-L1 is induced by the periodontal pathogen Porphyromonas gingivalis and can be blocked by small molecule gingipain inhibitors, including atuzaginstat" (November 9-14, 2020)
CTAD 2020 Oral Presentation #OC19: "Phase 2/3 GAIN trial of COR388 (atuzaginstat), a novel bacterial virulence factor inhibitor for the treatment of Alzheimer’s disease: Update and baseline Data" (November 5, 2020)
AAIC 2020 Poster #47058: “Targeting Porphyromonas gingivalis to treat Alzheimer’s disease and comorbid cardiovascular disease” (July 2020)
AAIC 2020 Poster #40578: “COR388 (atuzaginstat), a novel gingipain inhibitor, decreases fragmentation of ApoE in the central nervous system of Alzheimer's disease patients” (July 2020)
AAIC 2020 Poster #44023: “Comprehensive Alzheimer’s pathology is induced by Porphyromonas gingivalis infection: COR388 (atuzaginstat) and other gingipain inhibitors protect against synaptic loss” (July 2020)
